PAZ-417

DRUG4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Alzheimer DiseaseHealthy

Phase 1

A Study of the Safety of PAZ-417 in Healthy Elderly Adults

TerminatedNCT00663065

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2008-04-30End: 2008-12-31Target: 40Updated: 2009-08-04

Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects

CompletedNCT00684710

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease, Healthy

Start: 2008-04-30End: 2008-08-31Target: 56Updated: 2009-01-30

Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease

TerminatedNCT00739037

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease

Start: 2008-08-31End: 2008-12-31Target: 10Updated: 2009-08-04

Unknown Phase

Study Evaluating PAZ-417 in Healthy Young/Elderly

CompletedNCT00366288

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease

Start: 2006-07-31End: 2008-03-31Target: 56Updated: 2009-07-10